Volver a Agenda
Creating Value for Patients
Session Chair(s)
Jennifer Burgess, MBA, MPH
Vice President, Global Engagement and Communications
TransCelerate Biopharma Inc., United States
Creating Value for Patients
Learning Objective : Learning about the many challenges in the set-up of appropriate processes for the writing, review, approval and distribution of lay summaries, appeciating the complexity of providing translations of lay summaries for all study participants, appreciating the choices that need to be made for lay summaries of early phase trials
Speaker(s)
Bringing Lay Summaries to Fruition - How to Implement Appropriate Processes
Thomas Schindler, PHD
BioNTech SE, Germany
Director Global Regulatory Affairs - Regulatory Operations
Best Practices for Lay Summaries in Global Clinical Trials
Hugo Riu
Welocalize Life Sciences, Spain
Quality and Training Director
Enabling Patient Centric Clinical Trials: TransCelerate’s Patient Experience Initiative
Fabian Somers, PHD, MBA, MSC
UCB Biopharma, Belgium
Senior Clinical Program Director, NewMeds & Bone Clinical Development
Patient Engagement Through Patient Centricity
Srinivas Karri, MSC
Oracle Corporation, United Kingdom
Senior Director, Clinical Warehousing Cloud Strategy
¿Tiene una cuenta?